세계의 동물실험 및 동물실험 대체법 시장 : 기회와 전략(-2035년)

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

US $ 5,000 ￦ 6,883,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,325,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,767,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 동물실험 시장은 2023년 121억 9,000만 달러 규모로 성장하고, 2.0% 이상의 CAGR(연평균 성장률)을 기록할 것으로 예상됩니다.

제약사들의 연구개발 투자 증가

제약기업의 R&D(연구개발) 투자 증가는 동물실험 시장의 성장으로 이어집니다. 투자 비율은 해마다 증가하고 있으며, 제약회사는 연구개발에 가장 많이 투자하는 기업입니다. R&D형 제약사들이 R&D 투자를 늘리는 주요 요인은 미충족 의료 수요를 충족시킬 수 있는 신약의 발견과 개발로, 20-21년 인도 제약사들의 평균 R&D 비용은 총 매출의 7.2%로 Lupin, Alembic Pharma, Dr.Reddy's가 가장 많이 지출했습니다. 세계 상위 20개 제약사의 2022년 연구개발비는 총 1,390억 달러에 달합니다. 스위스의 의료 기업 Roche는 2022년에 140억 5,000만 스위스프랑(151억 5,000만 달러)을 R&D에 투자했습니다. 예를 들어, 세계 제약회사들은 2022년 연구개발에 총 1,390억 달러를 지출했습니다. 또한 연방정부 통계에 따르면 2019년 세계 제약사들은 평균적으로 매출의 약 25%를 연구개발에 투자하고 있습니다. 따라서 동물 모델에 대한 투자 증가는 제약 연구에 널리 채택될 것입니다. 이는 동물실험 시장을 견인할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 목차

제3장 표목차

제4장 그림목차

제5장 보고서 구조

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 동물실험과 동물실험 대체법 시장 정의와 세분화
  • 동물실험
  • 동물실험 대체법
  • 연구용 동물에 관한 사실 - 동물과 인체의 기능적 유사성
• 시장 세분화 : 최종 이용 산업별
  • 의약품
  • 학술 연구
  • 의료기기
  • 화학제품과 농약
  • 화장품
  • 기타

제7장 밸류체인 분석

• 동물 사육자와 공급자
• 동물실험 대체법 기술 개발자
• 규제 당국
• 대체 테스트 서비스 프로바이더
• 최종 이용 산업
• 임상시험

제8장 동물실험 대체법 시장 동향

• 윤리적인 대체 수단으로 Drug Discovery 기술을 가속하는 AI
• 약제 유효성을 시험하기 위한 in silico 시험 채용
• 시험의 모델 생물 사용
• 시험용 OOC(Organ-On-Chip) 개발
• 시험용 3D 프린트 장기에 주목
• 동물실험을 줄이기 위한 협력과 파트너십 확대
• 동물실험을 추진하는 대처와 조성금 증가

제9장 동물실험과 대체 기술 비용 분석

• 실험동물의 평균 비용
• 동물실험 대체법의 평균 비용
• 동물실험과 대체법의 비용 비교 분석
• 동물실험에 드는 비용, 2021

제10장 동물실험과 동물실험 대체법 시장 부문

• 최종 용도별 산업 용도
  • 중요한 사용 부문
  • 기초 조사
  • 응용 조사
  • 규제 테스트
  • 새로운 진단 방법 개발
  • 유전자 재조합 동물 번식
  • 동물 클론
• 최종사용자 용도
• 동물실험 시장 : 동물 유형별
  • 마우스
  • 쥐
  • 개구리
  • 어류
  • 조류
  • 기니피그
  • 햄스터
  • 토끼
  • 양
  • 개
  • 고양이
  • 원숭이
  • 돼지
  • 기타

제11장 연구에 사용된 동물 수 : 국가별

• USA
• 유럽
• 영국
• 독일
• 프랑스
• 호주
• 캐나다
• 중국

제12장 동물실험 대체법 기술 유형과 최종 용도별

• 소개
• 동물실험 대체법 기술 유형
  • 세포 또는 조직배양(인비트로)
  • 세계의 주요 세포배양 개발업체
  • 장기 칩(OOC)
  • 세계의 OOC 시장 규모와 성장
  • OOC 시장 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 인실리코(컴퓨터 기반 모델)
  • 인공 피부 모델(피부 대체품)
  • 기타

제13장 최종 이용 산업의 동물실험 대체법 기술 채용

• 업계별 대체 시험 기술 채용
  • 화장품 업계
  • 제약 업계
  • 의료기기 업계
  • 기타
• 미국의 3R 도입
• 중국의 3R 도입
• 유럽의 3R 도입

제14장 세계의 동물실험과 동물실험 대체법 시장

제15장 동물실험과 동물실험 대체법 시장, 지역과 국가별 분석

제16장 미국의 동물실험과 동물실험 대체법 시장

제17장 일본의 동물실험과 동물실험 대체법 시장

제18장 중국의 동물실험과 동물실험 대체법 시장

제19장 호주의 동물실험과 동물실험 대체법 시장

제20장 유럽의 동물실험과 동물실험 대체법 시장

제21장 프랑스의 동물실험과 동물실험 대체법 시장

제22장 독일의 동물실험과 동물실험 대체법 시장

제23장 영국의 동물실험과 동물실험 대체법 시장

제24장 캐나다의 동물실험과 동물실험 대체법 시장

제25장 기타 동물실험과 동물실험 대체법 시장

제26장 동물실험 대체법 경쟁 상황과 기업 개요

• 기업 개요
• Bio-Rad Laboratories, Inc.
• SGS SA
• Abbott Laboratories
• Evotec SE
• Emulate, Inc
• 미국의 동물실험 대체법 시장 경쟁 상황
• 기업 개요
• Charles River Laboratories
• Cyprotex
• Emulate, Inc
• BioIVT
• EMD Millipore
• 일본의 동물실험 대체법 시장 경쟁 상황
• 기업 개요
• Japan Tissue Engineering Co., Ltd.(J-TEC)
• ReproCell Inc
• Organ Technologies Co, Ltd
• 유럽의 동물실험 대체법 시장 경쟁 상황
• 기업 개요
• CN Bio Innovations, Ltd
• Cyprotex
• Certest Biotec
• XCellR8
• Gentronix Ltd

제27장 동물실험과 동물실험 대체법 세계 시장 기회와 전략

• 2035년 세계의 동물실험 시장 - 가장 새로운 기회를 제공하는 지역
• 2035년 세계의 동물실험 대체법 시장 - 가장 새로운 기회를 제공하는 지역
• 2035년 세계의 동물실험과 동물실험 대체법 시장 - 가장 새로운 기회를 제공하는 부문
• 2025년 세계의 동물실험과 동물실험 대체법 시장 - 성장 전략
  • 동물실험 대체법 시장 동향별 전략
  • 경쟁 전략

제28장 동물실험과 동물실험 대체법 시장 : 결론과 제안

• 결론
• 추천사항
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 인재

제29장 부록

• 통화
• Business Research Company
• 저작권과 면책사항

ksm

영문 목차

영문목차

Animal testing or in-vivo testing is the use of living animals in scientific experiments to assess the safety and effectiveness of new products developed in the biopharma, medical devices, chemicals, food and other industries. Animal testing allows scientists to understand how the human body might react to specific substances. The study on animals is a vital part of the research because the basic cell process and physiology of animals is similar to that of humans.

The animal testing market consists of the total expenses incurred by end-use entities that use animals for testing their products. End-use entities include academic research institutions and various industries (such as pharmaceuticals, medical devices, chemicals & pesticides and cosmetics,) that conduct animal testing during product development. Pharmaceutical and medical device companies also use animal testing to understand basic disease mechanisms. End-use entities may also outsource these tests to clinical research organizations (CROs). The animal testing market covered in this report includes sales of animal testing services by CROs to end use industries.

The Global animal testing market grew to $12.19 billion in 2023 at a compound annual growth rate (CAGR) of more than 2.0%.

Increasing Investment In R&D By The Pharmaceutical Companies

The rise in investment in R&D (research and development) by the pharma companies leads to the growth of the animal testing market. The rate of investment has been increasing over the years and pharmaceutical companies are the top investors in R&D. The key factor for research-based pharmaceutical companies investing more in R&D is the discovery and development of new drugs serving unmet medical needs. For FY20-21, the average R&D expenses of pharma companies in India were 7.2% of total revenues, with Lupin, Alembic Pharma and Dr. Reddy's spending more than others. The top 20 global pharmaceutical companies collectively spent $139 billion on R&D in 2022. Roche, a Swiss healthcare company, spent 14.05 billion Swiss francs ($15.15 billion) on R&D in 2022. For example, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Also in 2019, globally pharmaceutical companies spent an average of roughly 25% of their revenue on R&D, according to federal government statistics. Therefore, the increasing investment in animal models will be widely employed in pharmaceutical research. This is expected to drive the animal testing market.

AI To Accelerate Drug Discovery Technologies With Ethical Alternatives

Major non-animal testing technologies companies are focusing on AI (artificial intelligence) to accelerate drug discovery technologies with ethical alternatives to expand their businesses. AI plays a crucial role in enhancing the capabilities of both animal testing and non-animal alternative testing methods, ultimately advancing biomedical research while reducing the ethical concerns and limitations associated with animal experimentation. For example, in June 2023, Quantiphi, a US-based AI-driven digital engineering company, launched Digital Animal Replacement Technology (DART), which is a solution that offers a humane and accurate alternative to traditional animal testing for drug discovery, manufacturing and pre-clinical trials. DART combines human biology with advanced digital technologies to predict drug safety and efficacy accurately, eliminating the need for animal testing in many scenarios. The technology uses ethically sourced human stem cells, a Digital Workstation and AI to accelerate drug discovery while ensuring safety and efficacy. DART's launch represents a significant step towards more ethical, efficient and effective alternatives to animal testing in the pharmaceutical industry.

The global non-animal alternatives testing market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 10.95% of the total market in 2022.

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 8 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for animal testing and non-animal alternative testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The animal testing and non-animal alternative testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider animal testing and non-animal alternative testing market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions, and explanations about the animal testing and non-animal alternative testing market.
• Market Value Chain Analysis- This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets.

Non-Animal Alternative Testing Trends- This chapter describes the major trends shaping the global non-animal alternative testing market.

• Cost Analysis For Animal Testing and Alternative Technologies- This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods.
• Animal Testing And Non-Animal Alternative Testing By Type And End Use- This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies.
• End-User Industries Adoption to Alternative Technologies- This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe.
• Global Market Size This section provides information on the global animal testing and non-animal alternative testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support the growth of the market during this period.
• Regional And Country Analysis- This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies.
• Animal Testing Regulatory Landscape- This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies.
• Competitive Landscape For Alternative Technologies- This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies.
• Market Opportunities And Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
• Conclusions And Recommendations- This section includes recommendations for animal testing and non-animal alternative testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By End Use Industrial Application: Basic Research; Applied Research; Regulatory Testing; Development Of New Diagnostic Methods; Breeding Of Genetically Altered Animals; Animal Cloning
• 2) By End-Use Industry: Pharmaceutical; Academic Research; Medical Devices; Chemicals And Pesticides; Cosmetics; Other End Users
• 3) By Animal Type: Mice; Rats; Frogs; Fish; Birds; Guinea Pigs; Hamsters; Rabbits; Sheep; Dogs; Cats; Monkeys; Pigs; Others
• Companies Mentioned: Bio-Rad Laboratories, Inc.; SGS SA; Abbott; Evotec SE; Emulate, Inc
• Countries: Australia; China; Japan; USA; Canada; France; Germany; UK
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Animal Testing And Non-Animal Alternative Testing Market Definition And Segmentations
  • 6.3.1 Animal Testing
  • 6.3.2 Non-Animal Alternative Testing
  • 6.3.3 Facts About Animals In Research - Functional Resemblances Of Animals To Human Body
• 6.4 Market Segmentation By End-Use Industry
  • 6.4.1 Pharmaceuticals
  • 6.4.2 Academic Research
  • 6.4.3 Medical Devices
  • 6.4.4 Chemicals And Pesticides
  • 6.4.5 Cosmetics
  • 6.4.6 Other End Users

7 Value Chain Analysis

• 7.1 Animal Breeders and Suppliers
• 7.2 Non-Animal Alternative Testing Technology Developers
• 7.3 Regulatory Authorities
• 7.4 Alternative Testing Service Providers
• 7.5 End-Use Industries
• 7.6 Clinical Trials

8 Non-Animal Alternative Testing Market Trends

• 8.1 AI To Accelerate Drug Discovery Technologies With Ethical Alternatives
• 8.2 Adoption Of In Silico Trials To Test Efficacy Of Drugs
• 8.3 Use Of Model Organisms In Testing
• 8.4 Developments In OOC (Organ-On-Chip) For Testing
• 8.5 Focus On 3D-Printed Organs For Testing
• 8.6 Increasing Collaborations And Partnerships To Reduce Animal Testing
• 8.7 Rising Initiatives And Grants To Promote Animal-Free Testing

9 Cost Analysis For Animal Testing And Alternative Technologies

• 9.1 Average Cost Of Laboratory Animals
• 9.2 Average Cost Of Non-Animal Alternative Testing Methods
• 9.3 Comparative Cost Analysis For Animal Testing And Alternative Methods
• 9.4 Costs Involved In Animal Testing, 2021

10 Animal Testing And Non-Animal Alternative Testing Market Segments

• 10.1 By End Use Industrial Application
  • 10.1.1 Important Areas of Use
  • 10.1.2 Basic Research
  • 10.1.3 Applied Research
  • 10.1.4 Regulatory Testing
  • 10.1.5 Development Of New Diagnostic Methods
  • 10.1.6 Breeding Of Genetically Altered Animals
  • 10.1.7 Animal Cloning
• 10.2 End-User Applications
• 10.3 Animal Testing Market By Animal Type
  • 10.3.1 Mice
  • 10.3.2 Rat
  • 10.3.3 Frogs
  • 10.3.4 Fish
  • 10.3.5 Birds
  • 10.3.6 Guinea pig
  • 10.3.7 Hamster
  • 10.3.8 Rabbits
  • 10.3.9 Sheep
  • 10.3.10 Dogs
  • 10.3.11 Cats
  • 10.3.12 Monkeys
  • 10.3.13 Pigs
  • 10.3.14 Others

11 Number Of Animals Used In Research, By Country

• 11.1 USA
• 11.2 Europe
• 11.3 United Kingdom (UK)
• 11.4 Germany
• 11.5 France
• 11.6 Australia
• 11.7 Canada
• 11.8 China

12 Non-Animal Alternative Testing Technologies By Type And End Use

• 12.1 Introduction
• 12.2 Types Of Non-Animal Alternative Testing Technologies
  • 12.2.1 Cell Or Tissue Culture (In-Vitro)
  • 12.2.2 Major Cell Culture Developers Worldwide
  • 12.2.3 Organ-On-Chip (OOC)
  • 12.2.4 Global OOC Market Size And Growth
  • 12.2.5 OOC Market Drivers And Restraints
  • 12.2.6 Market Drivers
  • 12.2.7 Market Restraints
  • 12.2.8 In-silico (Computer-Based Models)
  • 12.2.9 Artificial Skin Models (Skin Substitutes)
  • 12.2.10 Other Technologies

13 End-User Industries Adoption Of Alternative Testing Technologies

• 13.1 Adoption of Alternative Testing Technologies By Type of Industry
  • 13.1.1 Cosmetics Industry
  • 13.1.2 Pharmaceutical Industry
  • 13.1.3 Medical Device Industry
  • 13.1.4 Others
• 13.2 Adoption of 3R's In USA
  • 13.2.1 3R Adoption In The Cosmetics Industry
  • 13.2.2 3R Adoption In The Pharmaceutical Industry
  • 13.2.3 3R Adoption In The Medical Device Industry
• 13.3 Adoption of 3R's In China
  • 13.3.1 3R Adoption In The Cosmetics Industry
  • 13.3.2 3R Adoption In The Pharmaceutical Industry
  • 13.3.3 3R Adoption In The Medical Device Industry
• 13.4 Adoption of 3R's In Europe
  • 13.4.1 3R Adoption In The Cosmetics Industry
  • 13.4.2 3R Adoption In The Pharmaceutical Industry
  • 13.4.3 3R Adoption In The Medical Device Industry

14 Global Animal Testing And Non-Animal Testing Market

• 14.1 Global Animal Testing Market Size And Growth
  • 14.1.1 Global Animal Testing Market Value ($ Billion)
  • 14.1.2 Global Animal Testing Market, By Volume (Million Units)
  • 14.1.3 Animal Testing Market Drivers
  • 14.1.4 Animal Testing Market Restraints
• 14.2 Global Non-Animal Alternative Testing Market Size And Growth
  • 14.2.1 Global Non-Animal Alternative Testing Market Value ($ Billion)
  • 14.2.2 Non-Animal Alternative Testing Market Drivers
  • 14.2.3 Non-Animal Alternative Testing Market Restraints

15 Animal Testing And Non-Animal Testing Market, Regional And Country Analysis

16 USA Animal Testing And Non-Animal Alternative Testing Market

• 16.1 USA Animal Testing Market
  • 16.1.1 USA Animal Testing Market Value ($ Billion)
  • 16.1.2 USA Animal Testing Market, By Volume (Million Units)
• 16.2 USA Non-Animal Alternative Testing Market
  • 16.2.1 USA Non-Animal Alternative Testing Market Value ($ Billion)
• 16.3 USA Animal Testing Market By End Use Industrial Application
  • 16.3.1 Market By Value And Volume
  • 16.3.2 122
  • 16.3.3 Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
• 16.4 Regulatory Landscape In The USA
  • 16.4.1 Regulatory Bodies & Policies
  • 16.4.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
  • 16.4.3 USDA & Animal Welfare Act
  • 16.4.4 ICCVAM
  • 16.4.5 FDA
  • 16.4.6 NIH
  • 16.4.7 Animal Welfare Act (AWA)

17 Japan Animal Testing And Non-Animal Alternative Testing Market

• 17.1 Japan Animal Testing Market
  • 17.1.1 Japan Animal Testing Market Value ($ Billion)
  • 17.1.2 Japan Animal Testing Market, By Volume (Million Units)
• 17.2 Japan Non-Animal Alternative Testing Market
  • 17.2.1 Japan Non-Animal Alternative Testing Market Value ($ Billion)
• 17.3 Japan Animal Testing Market By End Use Industrial Application
  • 17.3.1 Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
• 17.4 Regulatory Landscape In Japan
  • 17.4.1 Regulatory Bodies & Policies
  • 17.4.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
  • 17.4.3 Law for the Humane Treatment and Management of Animals
  • 17.4.4 MHLW, MEXT, PMDA And MAFF

18 China Animal Testing And Non-Animal Alternative Testing Market

• 18.1 China Animal Testing Market
  • 18.1.1 China Animal Testing Market Value ($ Billion)
  • 18.1.2 China Animal Testing Market, By Volume (Million Units)
• 18.2 Regulatory Landscape In China
  • 18.2.1 Regulatory Bodies & Policies
  • 18.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

19 Australia Animal Testing And Non-Animal Alternative Testing Market

• 19.1 Australia Animal Testing Market
  • 19.1.1 Australia Animal Testing Market Value ($ Billion)
  • 19.1.2 Australia Animal Testing Market, By Volume (Million Units)
• 19.2 Regulatory Landscape In Australia
  • 19.2.1 Regulatory Bodies & Policies
  • 19.2.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

20 Europe Animal Testing And Non-Animal Alternative Testing Market

• 20.1 Regulatory Landscape In Europe
  • 20.1.1 EU Directive 2010/63
• 20.2 Europe Non-Animal Alternative Testing Market
  • 20.2.1 Europe Non-Animal Alternative Testing Market Value ($ Billion)

21 France Animal Testing And Non-Animal Alternative Testing Market

• 21.1 France Animal Testing Market
  • 21.1.1 France Animal Testing Market Value ($ Billion)
  • 21.1.2 France Animal Testing Market, By Volume (Million Units)
• 21.2 France Animal Testing Market By End Use Industrial Application
  • 21.2.1 Market By Value
  • 21.2.2 160
• 21.3 Regulatory Landscape In France
  • 21.3.1 Regulatory Bodies & Policies
  • 21.3.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

22 Germany Animal Testing And Non-Animal Alternative Testing Market

• 22.1 Germany Animal Testing Market
  • 22.1.1 Germany Animal Testing Market Value ($ Billion)
  • 22.1.2 Germany Animal Testing Market, By Volume (Million Units)
• 22.2 Germany Animal Testing Market By End Use Industrial Application
  • 22.2.1 Market By Value
  • 22.2.2 168
• 22.3 Regulatory Landscape In Germany
  • 22.3.1 Regulatory Bodies & Policies
  • 22.3.2 Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

23 UK Animal Testing And Non-Animal Alternative Testing Market

• 23.1 UK Animal Testing Market
  • 23.1.1 UK Animal Testing Market Value ($ Billion)
  • 23.1.2 UK Animal Testing Market, By Volume (Million Units)
• 23.2 UK Animal Testing Market By End Use Industrial Application
  • 23.2.1 Market By Value
  • 23.2.2 176
• 23.3 Regulatory Landscape in United Kingdom (UK)
  • 23.3.1 Regulatory Bodies & Policies
  • 23.3.2 Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

24 Canada Animal Testing And Non-Animal Alternative Testing Market

• 24.1 Canada Animal Testing Market
  • 24.1.1 Canada Animal Testing Market Value ($ Billion)
  • 24.1.2 Canada Animal Testing Market, By Volume (Million Units)
• 24.2 Regulatory Landscape In Canada
  • 24.2.1 Regulatory Bodies & Policies
  • 24.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

25 Rest of the World (RoW) Animal Testing And Non-Animal Alternative Testing Market

• 25.1 Rest of the World (RoW) Animal Testing Market
  • 25.1.1 Rest of the World (RoW) Animal Testing Market Value ($ Billion)
  • 25.1.2 Rest of the World (RoW) Animal Testing Market, By Volume (Million Units)
• 25.2 Regulatory Landscape In Rest of the World (RoW)
  • 25.2.1 Regulatory Bodies & Policies
  • 25.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

26 Non-Animal Alternatives Testing Competitive Landscape And Company Profiles

• 26.1 Company Profiles
• 26.2 Bio-Rad Laboratories, Inc.
  • 26.2.1 Company Overview
  • 26.2.2 Products And Services
  • 26.2.3 Business Strategy
  • 26.2.4 Financial Overview
• 26.3 SGS SA
  • 26.3.1 Company Overview
  • 26.3.2 Products And Services
  • 26.3.3 Business Strategy
  • 26.3.4 Financial Overview
• 26.4 Abbott Laboratories
  • 26.4.1 Company Overview
  • 26.4.2 Products And Services
  • 26.4.3 Financial Overview
• 26.5 Evotec SE
  • 26.5.1 Company Overview
  • 26.5.2 Products And Services
  • 26.5.3 Business Strategy
  • 26.5.4 Financial Overview
• 26.6 Emulate, Inc
  • 26.6.1 Company Overview
  • 26.6.2 Products And Services
  • 26.6.3 Business Strategy
  • 26.6.4 Financial Overview
• 26.7 USA Non-Animal Alternative Testing Market Competitive Landscape
• 26.8 Company Profiles
• 26.9 Charles River Laboratories
  • 26.9.1 Company Overview
  • 26.9.2 Products And Services
  • 26.9.3 Business Strategy
  • 26.9.4 Financial Overview
• 26.10 Cyprotex
  • 26.10.1 Company Overview
  • 26.10.2 Products And Services
  • 26.10.3 Business Strategy
  • 26.10.4 Financial Overview
• 26.11 Emulate, Inc
  • 26.11.1 Company Overview
  • 26.11.2 Products And Services
  • 26.11.3 Business Strategy
  • 26.11.4 Financial Overview
• 26.12 BioIVT
  • 26.12.1 Company Overview
  • 26.12.2 Products And Services
  • 26.12.3 Business Strategy
  • 26.12.4 Financial Overview
• 26.13 EMD Millipore
  • 26.13.1 Company Overview
  • 26.13.2 Products And Services
  • 26.13.3 Business Strategy
  • 26.13.4 Financial Overview
• 26.14 Japan Non-Animal Alternative Testing Market Competitive Landscape
• 26.15 Company Profiles
• 26.16 Japan Tissue Engineering Co., Ltd. (J-TEC)
  • 26.16.1 Company Overview
  • 26.16.2 Products And Services
  • 26.16.3 Business Strategy
  • 26.16.4 Financial Overview
• 26.17 ReproCell Inc
  • 26.17.1 Company Overview
  • 26.17.2 Products And Services
  • 26.17.3 Financial Overview
• 26.18 Organ Technologies Co, Ltd
  • 26.18.1 Company Overview
  • 26.18.2 Products And Services
• 26.19 Europe Non-Animal Alternative Testing Market Competitive Landscape
• 26.20 Company Profiles
• 26.21 CN Bio Innovations, Ltd
  • 26.21.1 Company Overview
  • 26.21.2 Products And Services
  • 26.21.3 Business Strategy
  • 26.21.4 Financial Overview
• 26.22 Cyprotex
  • 26.22.1 Company Overview
  • 26.22.2 Products And Services
  • 26.22.3 Business Strategy
  • 26.22.4 Financial Overview
• 26.23 Certest Biotec
  • 26.23.1 Company Overview
  • 26.23.2 Products And Services
  • 26.23.3 Financial Overview
• 26.24 XCellR8
  • 26.24.1 Company Overview
  • 26.24.2 Products And Services
  • 26.24.3 Financial Overview
• 26.25 Gentronix Ltd
  • 26.25.1 Company Overview
  • 26.25.2 Products And Services
  • 26.25.3 Financial Overview

27 Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies

• 27.1 Global Animal Testing Market In 2035 - Geographies Offering Most New Opportunities
• 27.2 Global Non-Animal Alternative Testing Market In 2035 - Geographies Offering Most New Opportunities
• 27.3 Global Animal Testing And Non-Animal Alternative Testing Market In 2035 - Segments Offering Most New Opportunities
• 27.4 Global Animal Testing And Non-Animal Alternative Testing Market In 2025 - Growth Strategies
  • 27.4.1 Non-Animal Alternative Testing Market Trend Based Strategies
  • 27.4.2 Competitor Strategies

28 Animal Testing And Non-Animal Alternative Testing Market, Conclusions And Recommendations

• 28.1 Conclusions
• 28.2 Recommendations
  • 28.2.1 Product
  • 28.2.2 Place
  • 28.2.3 Price
  • 28.2.4 Promotion
  • 28.2.5 People

29 Appendix

• 29.1 Geographies Covered
• 29.2 Glossary
• 29.3 Market Data Sources
• 29.4 Research Methodology
  • 29.4.1 OCED Accepted In Vito Tests
• 29.5 Currencies
• 29.6 The Business Research Company
• 29.7 Copyright and Disclaimer

관련자료